In order to assess whether COX-2 might also be associated with dying oligodendrocytes in MS lesions, we stained MS lesions with an oligodendrocyte marker (CNPase) along with a marker for cell death (activated caspase 3) and asked whether COX-2 was associated with these markers. Here, PTGS2 is linked to myeloid sarcoma.